Lab11 Therapeutics Inc.
NY
- UEI
- Z4RTHLMK8YJ3
- CAGE
- 808J7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 223 Bedford Ave, Brooklyn, NY 11211, USA
- Website
- lab11therapeutics.org
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Transient gene therapy as broad spectrum antiviral | National Institute of Allergy and Infectious Diseases (NIH) | $767,796 |
Quick answers
Is Lab11 Therapeutics Inc. registered in SAM.gov?
Yes. Lab11 Therapeutics Inc.'s SAM.gov registration is active through December 8, 2026.
What is Lab11 Therapeutics Inc.'s most recent federal award?
Lab11 Therapeutics Inc.'s most recent federal grant award is Transient gene therapy as broad spectrum antiviral (R41AI164999), from National Institute of Allergy and Infectious Diseases (NIH), on September 1, 2021.
On GovTribe
See Lab11 Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors